Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

11 treatments under study, led by Control

Research Leaders

7 sponsors active, led by Hanan Jafar

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (1)
Phase 1 (3)
Phase 2 (1)

Trial Status

Completed3
Unknown2
Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Control1
  • Plateletrich Plasma Combined With Isometric Contractions Of Quadriceps1
  • Adipose Tissue Derived Mesenchymal Stem Cell1
  • Extracellular Vesicles1
  • Nonsurgical Intervention1

Active Sponsors

  • Hanan Jafar2
  • Fondazione IRCCS Policlinico San Matteo di Pavia1
  • Chengdu Sport University1
  • University of Jordan1
  • Abdalla Awidi Abbadi, MD1

Top Investigators

Related Conditions

  • Total Knee Arthroplasty1

Activity Timeline